We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLBE icon
1026
Global E Online
GLBE
$6.34B
– –
-24,587
Closed -$892K
GLNG icon
1027
Golar LNG
GLNG
$4.99B
– –
-66,317
Closed -$2.08M
GLOB icon
1028
Globant
GLOB
$1.41B
– –
-4,127
Closed -$736K
GOGO icon
1029
Gogo Inc
GOGO
$540M
– –
-17,369
Closed -$167K
GPI icon
1030
Group 1 Automotive
GPI
$4.01B
– –
-1,901
Closed -$565K
GPMT
1031
Granite Point Mortgage Trust
GPMT
$62.8M
– –
-31,317
Closed -$93K
GPRE icon
1032
Green Plains
GPRE
$1.15B
– –
-12,452
Closed -$197K
GSHD icon
1033
Goosehead Insurance
GSHD
$1.47B
– –
-7,394
Closed -$425K
GSM icon
1034
FerroAtlántica
GSM
$617M
– –
-47,770
Closed -$256K
GT icon
1035
Goodyear
GT
$2.04B
– –
-49,032
Closed -$557K
GTLB icon
1036
GitLab
GTLB
$5.55B
– –
-35,107
Closed -$1.75M
GWW icon
1037
W.W. Grainger
GWW
$66B
– –
-1,244
Closed -$1.12M
HBM icon
1038
Hudbay
HBM
$9.96B
– –
-18,704
Closed -$169K
HEES
1039
DELISTED
H&E Equipment Services
HEES
– –
-11,369
Closed -$502K
HIW icon
1040
Highwoods Properties
HIW
$3.73B
– –
-13,210
Closed -$347K
HLNE icon
1041
Hamilton Lane
HLNE
$3.83B
– –
-22,668
Closed -$2.8M
HNI icon
1042
HNI Corp
HNI
$3.09B
– –
-4,768
Closed -$215K
HSIC icon
1043
Henry Schein
HSIC
$9.64B
– –
-5,569
Closed -$357K
HUBB icon
1044
Hubbell
HUBB
$26.3B
– –
-2,080
Closed -$760K
HURN icon
1045
Huron Consulting
HURN
$1.89B
– –
-10,500
Closed -$1.03M
PPLI
1046
People Inc
PPLI
$3.15B
– –
-6,122
Closed -$235K
IAS
1047
DELISTED
Integral Ad Science
IAS
– –
-21,241
Closed -$206K
IBKR icon
1048
Interactive Brokers
IBKR
$41.1B
– –
-11,440
Closed -$351K
IBP icon
1049
Installed Building Products
IBP
$6.16B
– –
-11,523
Closed -$2.37M
IDXX icon
1050
Idexx Laboratories
IDXX
$43.9B
– –
-1,592
Closed -$776K
40 41
42
43 44

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.